Karthik Radhakrishnan serves as Executive at Opexa Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Karthik Radhakrishnan has executed 4 insider transactions totaling $88.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 8, 2015 involved exercising options for 50,000 shares valued at $0.
Karthik Radhakrishnan currently holds 124,659 shares of Opexa Therapeutics, Inc. (OPXA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karthik Radhakrishnan has been a net buyer of OPXA stock. They have purchased $88.6K and sold $0 worth of shares.
Karthik Radhakrishnan's most recent insider trade was on Apr 8, 2015, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 18, 2013 | OPXA | $13.6K | Purchase | 8,000 | $1.70 | Discretionary |
| Aug 8, 2013 | OPXA | $75.0K | Purchase | 50,000 | $1.50 | Discretionary |